Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 241–255 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3084 ATRX Gene Alpha‑Thalassemia/Mental Retardation Syndrome Genetic Test This test evaluates the ATRX gene for pathogenic variants associated with Alpha‑Thalassemia/Mental Retardation Syndrome (ATR‑X). It uses Next-Generation Sequencing (NGS) for compre...	Whole Blood (EDTA tube), Extracted DNA, or FTA Card (one drop)	3-4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRX gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No special preparation required", "May eat and drink normally", "Continue prescribed medications"] Indications ["Clinical suspicion of ATR‑X syndrome", "Confirmation of diagnosis", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81170-3 ICD-10: Q87.8, D56.0, F78.9 Clinical summary This test evaluates the ATRX gene for pathogenic variants associated with Alpha‑Thalassemia/Mental Retardation Syndrome (ATR‑X). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3333 ATRX Gene Sequencing (NGS) for Alpha‑Thalassemia/Mental Retardation Syndrome Test This test identifies pathogenic variants in the ATRX gene associated with X-linked alpha-thalassemia/mental retardation syndrome.	Whole blood (3–5 mL in EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRX gene", "Copy number changes in the ATRX gene"] Parameters [] Preparation ["No fasting required", "Hydrate well", "Provide Emirates ID for home collection"] Indications ["Suspected ATR-X syndrome based on clinical presentation", "Family history of ATR-X syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 84410-0 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the ATRX gene associated with X-linked alpha-thalassemia/mental retardation syndrome.
TEST-5737 ATXN1 Gene Spinocerebellar Ataxia Type 1 (SCA1) Autosomal Dominant Genetic Test This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN1 gene, confirming a diagnosis of Autosomal Dominant Spinocerebellar Ataxia Type 1 (SCA1).	Peripheral Whole Blood (5 mL)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN1 gene"] Parameters [] Preparation ["Inform phlebotomist about anticoagulant therapy"] Indications ["Diagnosis of suspected SCA1", "Predictive testing for at-risk family members", "Prognostic evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 94880-2 ICD-10: G11.0 Clinical summary This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN1 gene, confirming a diagnosis of Autosomal Dominant Spinocerebellar Ataxia Type 1 (SCA1).
TEST-5872 ATXN2 Gene Spinocerebellar Ataxia Type 2, Autosomal Dominant Genetic Test This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the ATXN2 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor."] Indications ["Symptomatic patients", "At-risk family members", "Individuals seeking proactive neurogenetic insight"] Measurement technique Confirm with laboratory Codes LOINC: 38153-2 ICD-10: G11.8 Clinical summary This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).
TEST-5885 ATXN3 Gene Spinocerebellar Ataxia Type 3 (SCA3) Genetic Test This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3 (SCA3). It provides precise repeat sizin...	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN3 gene", "Flanking variants within the ATXN3 gene"] Parameters [{"name": "CAG Repeat Size", "reference_range": "Normal: Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Individuals with clinical symptoms suggestive of SCA3", "Family history of SCA3", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 47528-5 ICD-10: G11.3 Clinical summary This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3 (SCA3). It provides precise repeat sizing and detects flanking variants.
TEST-5800 ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test This test detects CAG repeat expansions in the ATXN7 gene, which are the cause of Spinocerebellar Ataxia Type 7.	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG repeat expansion in the ATXN7 gene"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Suspected Spinocerebellar Ataxia Type 7", "Progressive ataxia with family history"] Measurement technique Confirm with laboratory Codes LOINC: 92747-7 ICD-10: G11.8 Clinical summary This test detects CAG repeat expansions in the ATXN7 gene, which are the cause of Spinocerebellar Ataxia Type 7.
TEST-5806 ATXN8OS Gene Spinocerebellar Ataxia Type 8 Genetic Test This genetic test identifies CTG repeat expansions in the ATXN8OS gene, which are the cause of autosomal dominant spinocerebellar ataxia type 8 (SCA8).	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTG repeat expansions in the ATXN8OS gene", "Allele size", "Clinical pathogenicity"] Parameters [] Preparation ["Continue prescribed medications", "Mandatory pre-test genetic counselling session", "Avoid anticoagulant medications (e.g., aspirin) for 24 hours prior if providing a dried blood spot"] Indications ["Suspected SCA8 based on clinical presentation", "Family history of SCA8", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 101370-4 ICD-10: G11.2 Clinical summary This genetic test identifies CTG repeat expansions in the ATXN8OS gene, which are the cause of autosomal dominant spinocerebellar ataxia type 8 (SCA8).
TEST-3948 Atypical Hemolytic Uremic Syndrome (aHUS) Panel Genetic Test This test identifies pathogenic variants in over 20 genes associated with atypical hemolytic uremic syndrome (aHUS) using next-generation sequencing.	Peripheral whole blood (EDTA tube) or FTA card	3–4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in complement regulatory genes", "Pathogenic variants in coagulation factor genes"] Parameters [] Preparation ["No fasting required", "Inform lab of recent blood transfusions (within 1 week)", "Inform lab of current medications"] Indications ["Suspected diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Family history of aHUS", "Guiding targeted therapy selection (Eculizumab, Ravulizumab)", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 93505-2 ICD-10: D59.3 Clinical summary This test identifies pathogenic variants in over 20 genes associated with atypical hemolytic uremic syndrome (aHUS) using next-generation sequencing.
TEST-5928 AUH Gene 3-Methylglutaconic Aciduria Type 1 Genetic Test This genetic test identifies pathogenic variants in the AUH gene associated with 3-methylglutaconic aciduria type 1.	Peripheral whole blood (EDTA) or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AUH gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected 3-methylglutaconic aciduria type 1", "Family history of 3-methylglutaconic aciduria type 1"] Measurement technique Confirm with laboratory Codes LOINC: 82153-2 ICD-10: E71.111 Clinical summary This genetic test identifies pathogenic variants in the AUH gene associated with 3-methylglutaconic aciduria type 1.
TEST-3413 AURKC Gene SPGF5 Genetic Test This test detects pathogenic variants in the AURKC gene associated with spermatogenic failure type 5 (SPGF5), a cause of male infertility.	Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot on an FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AURKC gene"] Parameters [] Preparation [] Indications ["Unexplained azoospermia or severe oligospermia", "Family history of SPGF5", "Carrier screening in consanguineous families"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N46.0, N46.8 Clinical summary This test detects pathogenic variants in the AURKC gene associated with spermatogenic failure type 5 (SPGF5), a cause of male infertility.
TEST-1839 Autism Gene Panel Test This test identifies pathogenic variants in over 200 genes associated with autism spectrum disorder using next-generation sequencing.	['Peripheral whole blood', 'Amniotic fluid', 'Chorionic villi']	4–6 weeks (from sample receipt)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Clinically significant variants in genes associated with autism spectrum disorder", "Analytical sensitivity", "Diagnostic sensitivity"] Parameters [] Preparation ["No specific fasting required for blood samples", "Physician's prescription required for blood collection (exceptions apply)", "Obstetrician-specialist referral mandatory for prenatal samples"] Indications ["Individuals with features of autism spectrum disorder", "Family planning evaluations when a genetic cause is suspected", "Strong family history of autism spectrum disorder"] Measurement technique Confirm with laboratory Codes LOINC: 98173-3 ICD-10: ['Z13.41', 'F84.0', 'Z84.8'] Clinical summary This test identifies pathogenic variants in over 200 genes associated with autism spectrum disorder using next-generation sequencing.
TEST-6317 AVP Gene (Arginine Vasopressin) Neurohypophyseal Diabetes Insipidus Genetic Test (NGS) This test evaluates the AVP gene for mutations causing inherited neurohypophyseal diabetes insipidus.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AVP gene mutations", "Copy Number Variants (CNVs) in AVP gene"] Parameters [] Preparation ["Pre-test genetic counseling session required", "No specific fasting or medication adjustments needed"] Indications ["Suspected familial neurohypophyseal diabetes insipidus", "Differentiation from nephrogenic or primary polydipsia disorders", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 89283-2 ICD-10: E23.2 Clinical summary This test evaluates the AVP gene for mutations causing inherited neurohypophyseal diabetes insipidus.
TEST-3910 AVPR1A Gene (Autism) Genetic Test This test evaluates the AVPR1A gene for variants associated with an increased risk of autism spectrum disorder.	Whole Blood or FTA Card (Dried Blood Spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AVPR1A gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required.", "No medication adjustments required."] Indications ["Individuals with clinical features suggestive of Autism Spectrum Disorder", "Family history of ASD"] Measurement technique Confirm with laboratory Codes LOINC: 95818-3 ICD-10: F84.0, Z13.89 Clinical summary This test evaluates the AVPR1A gene for variants associated with an increased risk of autism spectrum disorder.
TEST-4140 B3GALNT2 Gene NGS Test for Congenital Muscular Dystrophy with α‑Dystroglycan Hypoglycosylation This test evaluates the B3GALNT2 gene for pathogenic variants associated with congenital muscular dystrophy-dystroglycanopathy.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GALNT2 gene", "Abnormal glycosylation of α-dystroglycan"] Parameters [] Preparation ["No fasting required"] Indications ["Suspicion of congenital muscular dystrophy-dystroglycanopathy", "Family history of the condition", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 62357-4 ICD-10: G71.0 Clinical summary This test evaluates the B3GALNT2 gene for pathogenic variants associated with congenital muscular dystrophy-dystroglycanopathy.
TEST-4557 B3GALT6 Gene Analysis (Spondyloepimetaphyseal Dysplasia with Joint Laxity Type 1) Test This test identifies pathogenic variants in the B3GALT6 gene, confirming a diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1).	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GALT6 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1)", "Family history of SEMD-JL1"] Measurement technique Confirm with laboratory Codes LOINC: 95240-3 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants in the B3GALT6 gene, confirming a diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories